| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics, Inc. | Chairman and CEO, Director | Common Stock | 199,202 | $113,545 | $0.5700 | 22 Jun 2022 | Direct |
| Qualigen Therapeutics, Inc. | Chairman and CEO, Director | Common Stock | 11,005 | $6,273 | $0.5700 | 22 Jun 2022 | By IRA |
| Qualigen Therapeutics, Inc. | Chairman and CEO, Director | Stock Option (Right to Buy) | 375,000 | 11 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QLGN | Qualigen Therapeutics, Inc. | 11 Jul 2022 | 1 | $0 | 4 | Chairman and CEO, Director | 04 Aug 2022, 16:16 |
| QLGN | Qualigen Therapeutics, Inc. | 22 Jun 2022 | 1 | +$17,100 | 4 | Chairman and CEO, Director | 22 Jun 2022, 16:55 |